Center for the Integration of Research and Practice (CIRP), National Development and Research Institutes, Inc., New York, NY 10010, USA.
J Subst Abuse Treat. 2012 Apr;42(3):247-59. doi: 10.1016/j.jsat.2011.07.011. Epub 2011 Sep 22.
This article describes a randomized study to determine the effectiveness of a reentry modified therapeutic community (RMTC) for offenders with co-occurring substance use and mental disorders (co-occurring disorders or COD). Men with COD, approved for community corrections placement postrelease, were recruited from nine Colorado prisons and stratified according to the type of treatment received while incarcerated (i.e., a prison modified therapeutic community [MTC] program or standard care). When released, each offender was randomly assigned either to the experimental RMTC (E-RMTC) condition (n = 71) or to the control parole supervision and case management (PSCM) condition (n = 56). An intent-to-treat analysis 12 months postprison release showed that the E-RMTC participants were significantly less likely to be reincarcerated (19% vs. 38%), with the greatest reduction in recidivism found for participants who received MTC treatment in both settings. These findings support the RMTC as a stand-alone intervention and provide initial evidence for integrated MTC programs in prison and in aftercare for offenders with COD.
本文描述了一项随机研究,旨在确定再入式改良治疗社区(RMTC)对同时存在物质使用和精神障碍(共病障碍或 COD)的罪犯的有效性。从科罗拉多州的 9 所监狱招募了具有 COD 的男性,他们在获释后被批准接受社区矫正,根据入狱期间接受的治疗类型进行分层(即监狱改良治疗社区 [MTC] 计划或标准护理)。当释放时,每个罪犯被随机分配到实验组 RMTC(E-RMTC)条件(n=71)或对照组假释监督和案例管理(PSCM)条件(n=56)。监狱释放后 12 个月的意向治疗分析表明,E-RMTC 参与者再次入狱的可能性明显降低(19% 对 38%),在接受两种环境下 MTC 治疗的参与者中,复发率的降低最大。这些发现支持 RMTC 作为一种独立的干预措施,并为监狱和 COD 罪犯康复后整合 MTC 项目提供了初步证据。